AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Healthcare Brew

Published November 13, 2026

How hospital leaders view psychedelics - Healthcare Brew

Read the full story at Healthcare Brew

Psychedelics news has been everywhere lately. Psilocybin (magic mushrooms) is being tested for treatment-resistant depression (TRD), LSD is being.

Post on X

Share this story

Surfaced by 4 Google Alerts

Psychedelics
LSD
Magic mushrooms
MDMA